1. Which of the following receptors is an ionotropic receptor that mediates fast excitatory synaptic transmission in the central nervous system?
a. Muscarinic acetylcholine receptor
b. NMDA receptor
c. Beta-adrenergic receptor
d. GABA B receptor
e. AMPA receptor
Show Answer
**Answer:** (e) AMPA receptor
2. Which receptor subtype is primarily responsible for the slowing of heart rate and stimulation of digestion?
a. Nicotinic acetylcholine receptor
b. M3 muscarinic acetylcholine receptor
c. Alpha 2 adrenergic receptor
d. M2 muscarinic acetylcholine receptor
e. Beta 1 adrenergic receptor
Show Answer
**Answer:** (d) M2 muscarinic acetylcholine receptor
3. Activation of which receptor subtype leads to bronchodilation and is targeted by drugs for asthma treatment?
a. Alpha 1 adrenergic receptor
b. Beta 1 adrenergic receptor
c. Beta 2 adrenergic receptor
d. D2 dopamine receptor
e. 5-HT3 serotonin receptor
Show Answer
**Answer:** (c) Beta 2 adrenergic receptor
4. Which of the following is NOT a type of glutamate receptor?
a. AMPA receptor
b. Kainate receptor
c. NMDA receptor
d. Metabotropic glutamate receptor
e. Nicotinic acetylcholine receptor
Show Answer
**Answer:** (e) Nicotinic acetylcholine receptor
5. Which neurotransmitter primarily activates 5-HT3 receptors, leading to nausea and vomiting?
a. Dopamine
b. Norepinephrine
c. Serotonin
d. GABA
e. Acetylcholine
Show Answer
**Answer:** (c) Serotonin
6. Which type of receptor is directly coupled to an ion channel, allowing for rapid changes in membrane potential?
a. Metabotropic receptor
b. G protein-coupled receptor
c. Tyrosine kinase receptor
d. Ionotropic receptor
e. Nuclear receptor
Show Answer
**Answer:** (d) Ionotropic receptor
7. Which neurotransmitter is the primary inhibitory neurotransmitter in the brain?
a. Glutamate
b. GABA
c. Dopamine
d. Serotonin
e. Acetylcholine
Show Answer
**Answer:** (b) GABA
8. Activation of which receptor subtype is associated with the “fight or flight” response?
a. Muscarinic acetylcholine receptor
b. Alpha 2 adrenergic receptor
c. Beta 2 adrenergic receptor
d. D1 dopamine receptor
e. 5-HT1A serotonin receptor
Show Answer
**Answer:** (b) Alpha 2 adrenergic receptor
9. What is the primary mechanism of action of opioid receptors?
a. Inhibition of adenylyl cyclase
b. Activation of phospholipase C
c. Opening of potassium channels
d. Closing of calcium channels
e. Activation of sodium channels
Show Answer
**Answer:** (a) Inhibition of adenylyl cyclase
10. Which receptor subtype is targeted by antipsychotic medications to manage symptoms of schizophrenia?
a. D1 dopamine receptor
b. D2 dopamine receptor
c. 5-HT2A serotonin receptor
d. NMDA glutamate receptor
e. Alpha 1 adrenergic receptor
Show Answer
**Answer:** (b) D2 dopamine receptor
11. Which receptor type is responsible for the sensation of pain?
a. Mechanoreceptors
b. Thermoreceptors
c. Nociceptors
d. Chemoreceptors
e. Photoreceptors
Show Answer
**Answer:** (c) Nociceptors
12. What type of receptor is the 5-HT1A receptor?
a. Ionotropic
b. Metabotropic
c. Kinase-linked
d. Nuclear
e. Ligand-gated ion channel
Show Answer
**Answer:** (b) Metabotropic
13. Which neurotransmitter binds to NMDA receptors, along with glutamate, to facilitate their activation?
a. Glycine
b. GABA
c. Dopamine
d. Serotonin
e. Acetylcholine
Show Answer
**Answer:** (a) Glycine
14. Which of the following receptors is NOT a G protein-coupled receptor (GPCR)?
a. Muscarinic acetylcholine receptor
b. Beta-adrenergic receptor
c. Dopamine receptor
d. 5-HT2A serotonin receptor
e. Nicotinic acetylcholine receptor
Show Answer
**Answer:** (e) Nicotinic acetylcholine receptor
15. Which neurotransmitter is the primary excitatory neurotransmitter in the central nervous system?
a. Glutamate
b. GABA
c. Dopamine
d. Serotonin
e. Acetylcholine
Show Answer
**Answer:** (a) Glutamate
16. Which receptor undergoes desensitization upon prolonged exposure to its agonist, leading to a reduced response over time?
a. NMDA receptor
b. 5-HT3 receptor
c. GABAA receptor
d. D2 dopamine receptor
e. Beta-adrenergic receptor
Show Answer
**Answer:** (e) Beta-adrenergic receptor
17. Which neurotransmitter receptor is implicated in the pathophysiology of Alzheimer’s disease, and is targeted by drugs like memantine?
a. AMPA receptor
b. NMDA receptor
c. Kainate receptor
d. GABA A receptor
e. Nicotinic acetylcholine receptor
Show Answer
**Answer:** (b) NMDA receptor
18. Which neurotransmitter receptor subtype is a target for atypical antipsychotic medications due to its involvement in both positive and negative symptoms of schizophrenia?
a. 5-HT2A serotonin receptor
b. D2 dopamine receptor
c. Alpha 1 adrenergic receptor
d. M1 muscarinic acetylcholine receptor
e. H1 histamine receptor
Show Answer
**Answer:** (a) 5-HT2A serotonin receptor
19. Which receptor undergoes phosphorylation as a mechanism of desensitization and internalization?
a. AMPA receptor
b. Nicotinic acetylcholine receptor
c. GABAA receptor
d. Beta-adrenergic receptor
e. 5-HT3 receptor
Show Answer
**Answer:** (d) Beta-adrenergic receptor
20. Which receptor is responsible for the reinforcing effects of drugs of abuse, such as cocaine and amphetamines?
a. D1 dopamine receptor
b. D2 dopamine receptor
c. Mu opioid receptor
d. Nicotinic acetylcholine receptor
e. CB1 cannabinoid receptor
Show Answer
**Answer:** (b) D2 dopamine receptor
21. A patient presents with ptosis (drooping eyelids), diplopia (double vision), and difficulty swallowing. These symptoms are suggestive of an autoimmune disorder affecting a specific receptor at the neuromuscular junction. Which receptor is most likely targeted by the autoantibodies?
a. Muscarinic acetylcholine receptor
b. Nicotinic acetylcholine receptor
c. Beta-adrenergic receptor
d. D2 dopamine receptor
e. 5-HT3 serotonin receptor
Show Answer
**Answer:** (b) Nicotinic acetylcholine receptor
22. Researchers are developing a novel medication for psychosis. This experimental drug acts as an antagonist at a receptor subtype known to be involved in the positive symptoms of schizophrenia. Preliminary results show the drug effectively reduces hallucinations and delusions. Which receptor subtype is this drug likely targeting?
a. 5-HT1A serotonin receptor
b. D2 dopamine receptor
c. Alpha 2 adrenergic receptor
d. M1 muscarinic acetylcholine receptor
e. H1 histamine receptor
Show Answer
**Answer:** (b) D2 dopamine receptor
23. A physician prescribes a medication for a patient with treatment-resistant depression. The medication is a combination of a selective serotonin reuptake inhibitor (SSRI) and a norepinephrine reuptake inhibitor (NRI). What is the rationale behind using this combination therapy?
a. To increase the availability of both serotonin and norepinephrine in the brain
b. To decrease the side effects associated with SSRIs
c. To enhance the activity of dopamine receptors
d. To block the reuptake of GABA
e. To increase the levels of acetylcholine in the brain
Show Answer
**Answer:** (a) To increase the availability of both serotonin and norepinephrine in the brain
24. A team of scientists is investigating a new compound that appears to enhance cognitive function and memory in animal models. This compound acts by modulating a specific type of glutamate receptor found abundantly in the hippocampus. Which receptor is most likely the target of this compound?
a. AMPA receptor
b. Kainate receptor
c. NMDA receptor
d. Metabotropic glutamate receptor 5 (mGluR5)
e. Nicotinic acetylcholine receptor
Show Answer
**Answer:** (c) NMDA receptor
25. A patient presents with dizziness and lightheadedness upon standing, along with a significant drop in blood pressure. The physician suspects orthostatic hypotension and prescribes a medication that targets a specific receptor subtype to counteract the decrease in blood pressure. Which receptor subtype is the medication most likely targeting?
a. Beta 2 adrenergic receptor
b. Alpha 1 adrenergic receptor
c. M2 muscarinic acetylcholine receptor
d. 5-HT1D serotonin receptor
e. D1 dopamine receptor
Show Answer
**Answer:** (b) Alpha 1 adrenergic receptor
26. A patient experiences tremors and muscle stiffness. Neurological tests reveal a decrease in dopamine levels in a specific brain region. Which region is most likely affected?
a. Hippocampus
b. Amygdala
c. Hypothalamus
d. Substantia nigra
e. Cerebellum
Show Answer
**Answer:** (d) Substantia nigra
27. A new drug, designed to alleviate chronic pain, has shown promising results in clinical trials. The drug’s mechanism of action involves binding to a specific receptor that is also activated by endogenous opioids like endorphins. Which receptor is this drug likely targeting?
a. Delta opioid receptor
b. Mu opioid receptor
c. Kappa opioid receptor
d. Nicotinic acetylcholine receptor
e. 5-HT3 serotonin receptor
Show Answer
**Answer:** (b) Mu opioid receptor
28. An individual experiences a heightened sense of alertness, increased heart rate, and dilated pupils after consuming a substance. This physiological response is likely due to the activation of which receptor type?
a. Muscarinic acetylcholine receptors
b. Nicotinic acetylcholine receptors
c. Adrenergic receptors
d. Dopamine receptors
e. GABA receptors
Show Answer
**Answer:** (c) Adrenergic receptors
29. A research team is studying a novel compound that shows potential as a treatment for anxiety disorders. The compound is found to enhance the activity of a specific type of receptor that is widely distributed throughout the brain and is involved in inhibitory neurotransmission. Which receptor is this compound most likely targeting?
a. Glutamate receptor
b. GABA receptor
c. Dopamine receptor
d. Serotonin receptor
e. Acetylcholine receptor
Show Answer
**Answer:** (b) GABA receptor
30. A patient with a history of substance abuse is undergoing treatment with a medication that blocks the rewarding effects of addictive drugs. This medication is designed to antagonize a specific receptor subtype involved in the reinforcement of drug-seeking behavior. Which receptor subtype is most likely the target of this medication?
a. D1 dopamine receptor
b. D2 dopamine receptor
c. Mu opioid receptor
d. Nicotinic acetylcholine receptor
e. CB1 cannabinoid receptor
Show Answer
**Answer:** (b) D2 dopamine receptor